dermatology
Novartis to acquire Fougera for $1.5 billion
May 3, 2012Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya
Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash. Novartis’ generic unit Sandoz is conducting the …
Sanofi spots acne vaccine opportunity
September 22, 2011Research and Development Sanofi, acne, dermatology
Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …
Sanofi sells dermatology unit for $425m
July 11, 2011Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi, Valeant, dermatology
Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …
AZ partners with Galderma on psoriasis research
March 9, 2011Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis
AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …
